The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

ABL Bio to present BBB and 4-1BB platforms at BIO-Europe 2026

Nov 5, 2026 05:52 (2h ago)

Verifying

ABL Bio plans to discuss Grabody-B and Grabody-T collaborations at BIO-Europe 2026.
November 9–11 marks the Cologne event dates, held in Germany local time.
Givastomig is in Phase 2 testing with Nivolumab and chemotherapy for metastatic gastric cancer.